Cambridge Nutritional Sciences (FRA:RVKA) OCF Margin %: -20.08% (As of Sep. 2025)


What is Cambridge Nutritional Sciences OCF Margin %?

Cambridge Nutritional Sciences FRA:RVKA OCF Margin % is -20.08% as of Sep. 2025. The stock has 3 warning signs investors should review. Among 815 Medical Devices & Instruments companies, Cambridge Nutritional Sciences ranks worse than 65.89% on this metric.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. Cambridge Nutritional Sciences's Cash Flow from Operations for the six months ended in Sep. 2025 was €-0.89 Mil. Cambridge Nutritional Sciences's Revenue for the six months ended in Sep. 2025 was €4.45 Mil. Therefore, Cambridge Nutritional Sciences's OCF Margin % for the quarter that ended in Sep. 2025 was -20.08%.

As of today, Cambridge Nutritional Sciences's current OCF Yield % is -6.48%.

The historical rank and industry rank for Cambridge Nutritional Sciences's OCF Margin % or its related term are showing as below:

FRA:RVKA' s OCF Margin % Range Over the Past 10 Years
Min: -41.77   Med: 1.77   Max: 14.12
Current: -3.04

During the past 13 years, the highest OCF Margin % of Cambridge Nutritional Sciences was 14.12%. The lowest was -41.77%. And the median was 1.77%.

FRA:RVKA's OCF Margin % is ranked worse than
65.89% of 815 companies
in the Medical Devices & Instruments industry
Industry Median: 5.86 vs FRA:RVKA: -3.04

Cambridge Nutritional Sciences OCF Margin % Related Terms

Cambridge Nutritional Sciences OCF Margin % Historical Data

* Premium members only.

The historical data trend for Cambridge Nutritional Sciences's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cambridge Nutritional Sciences OCF Margin % Chart

Cambridge Nutritional Sciences Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
OCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -35.49 -37.82 -41.77 6.21 -0.68

Cambridge Nutritional Sciences Semi-Annual Data
Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25
OCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -11.59 24.35 -13.62 12.06 -20.08

FRA:RVKA vs ISRG, BDX, MDLN: OCF Margin % Comparison

For the Medical Instruments & Supplies subindustry, Cambridge Nutritional Sciences's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cambridge Nutritional Sciences OCF Margin % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Cambridge Nutritional Sciences's OCF Margin % distribution charts can be found below:

* The bar in red indicates where Cambridge Nutritional Sciences's OCF Margin % falls into.


Cambridge Nutritional Sciences OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

Cambridge Nutritional Sciences's OCF Margin for the fiscal year that ended in Mar. 2025 is calculated as

OCF Margin=Cash Flow from Operations (A: Mar. 2025 )/Revenue (A: Mar. 2025 )
=-0.068/9.955
=-0.68 %

Cambridge Nutritional Sciences's OCF Margin for the quarter that ended in Sep. 2025 is calculated as

OCF Margin=Cash Flow from Operations (Q: Sep. 2025 )/Revenue (Q: Sep. 2025 )
=-0.893/4.448
=-20.08 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of -20.08% mean?
Cambridge Nutritional Sciences (FRA:RVKA) has a OCF Margin % of -20.08% as of Sep. 2025. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Cambridge Nutritional Sciences and its competitors. According to the industry distribution chart, Cambridge Nutritional Sciences ranks #537 out of 815 companies in the Medical Devices & Instruments industry, placing it in the top 65.9%.
Is Cambridge Nutritional Sciences' OCF Margin % too high?
Cambridge Nutritional Sciences' current OCF Margin % is -20.08%. Based on the distribution chart, Cambridge Nutritional Sciences ranks #537 out of 815 companies in the Medical Devices & Instruments industry, which is below the industry midpoint.
How does Cambridge Nutritional Sciences' OCF Margin % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Cambridge Nutritional Sciences ranks #537 out of 815 companies for OCF Margin %. This places Cambridge Nutritional Sciences in the lower half of its industry. The industry median OCF Margin % is 5.86. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Medical Devices & Instruments company?
The median OCF Margin % among Medical Devices & Instruments companies is 5.86, based on 815 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Cambridge Nutritional Sciences and its competitors. For the Medical Devices & Instruments industry, the median OCF Margin % is 5.86 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cambridge Nutritional Sciences's current OCF Margin % is -20.08%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cambridge Nutritional Sciences stock overvalued right now?
Based on GuruFocus' analysis, Cambridge Nutritional Sciences (FRA:RVKA) is currently considered Possible Value Trap. The stock's GF Value™ is €0.02, compared to a current price of €0.01 — trading 32.5% below its estimated fair value. The current OCF Margin % is -20.08%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Cambridge Nutritional Sciences (FRA:RVKA), the current OCF Margin % is -20.08% as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Cambridge Nutritional Sciences Business Description

Other Exchanges CNSL:UK
Address One Fleet Place, London, GBR, EC4M 7WS
Cambridge Nutritional Sciences PLC is a medical diagnostics company specializing in the development, manufacture, and distribution of food sensitivity test kits. Its product portfolio includes tests designed to detect immune reactions to various foods, helping healthcare professionals and patients identify dietary and lifestyle changes to improve long-term health and wellbeing. The company operates in the United Kingdom and serves the customer base across various countries through laboratories and healthcare providers. It generates revenue by selling diagnostic kits and providing clinical analysis services centered on food sensitivity and gut health. The group has two reportable segments: Health and Nutrition; and Corporate. The Health and Nutrition segment generates majority revenue.